Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Consumer Cyclical Technology Scientific & Technical Instruments Industrials
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

PR Newswire June 22, 2021

Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore

PR Newswire May 19, 2021

Cryoport Expands Global Supply Chain Network with Belgium Acquisition

PR Newswire May 18, 2021

LabConnect and Cryoport Partner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial

PR Newswire May 6, 2021

Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021

PR Newswire May 4, 2021

Cryoport to Report First Quarter 2021 Financial Results on May 4, 2021

PR Newswire April 27, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cryoport, Inc. (CYRX)

Newsfile April 8, 2021

Cryoport Acquires Temperature-Controlled Logistics Provider in Australia

PR Newswire April 6, 2021

Cryoport Announces Appointment of Linda Baddour to its Board of Directors

PR Newswire March 3, 2021

Cryoport Reports Record Results for Full Year 2020

PR Newswire March 1, 2021

Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021

PR Newswire February 25, 2021

Cryoport Launches Environmental, Social, and Governance (ESG) Program

PR Newswire February 25, 2021

Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock

PR Newswire February 8, 2021

Cryoport Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters to Purchase Additional Shares

PR Newswire January 25, 2021

Cryoport Announces Pricing of Public Offering of Common Stock

PR Newswire January 20, 2021

Cryoport Announces Proposed Public Offering of Common Stock

PR Newswire January 19, 2021

Cryoport and CCRM Fertility Enter Into Agreement

PR Newswire December 8, 2020

Cryoport Reports 2020 Third-Quarter Results

PR Newswire November 5, 2020

Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020

PR Newswire October 29, 2020

Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP

PR Newswire October 1, 2020